# EDGAR Filing Document

**Accession Number:** 0001868640
**File Stem:** 0001493152-25-025351
**Filing Date:** 2025-11
**Character Count:** 127562
**Document Hash:** bd12d4be2ab816a4c34127f6d62546e4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-025351.hdr.sgml**: 20251128

**ACCESSION NUMBER**: 0001493152-25-025351

**CONFORMED SUBMISSION TYPE**: S-3

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20251128

**DATE AS OF CHANGE**: 20251128

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Roadzen Inc.
- **CENTRAL INDEX KEY:** 0001868640
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 981600102
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** S-3
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291840
- **FILM NUMBER:** 251534375

**BUSINESS ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010
- **BUSINESS PHONE:** 650-414-3530

**MAIL ADDRESS:**
- **STREET 1:** 111 ANZA BLVD., SUITE 109
- **CITY:** BURLINGAME
- **STATE:** CA
- **ZIP:** 94010

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vahanna Tech Edge Acquisition I Corp.
- **DATE OF NAME CHANGE:** 20210621

**As filed with the Securities and Exchange Commission on November 28, 2025**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-3**

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933**

**ROADZEN INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **British Virgin Islands** | **98-1600102** |
| (State or other jurisdiction of | (I.R.S. Employer |
| incorporation or organization) | Identification Number) |

---

**111 Anza Boulevard, Suite 109<br> Burlingame, California 94010<br> (650) 414-3530**

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)**

**Rohan Malhotra<br> CEO and Director<br> 111 Anza Boulevard, Suite 109<br> Burlingame, California 94010<br> (650) 414-3530**

**(Name, address, including zip code, and telephone number, including area code, of agent for service)**

***Copies to:***

**Jason T. Simon, Esq.<br> Greenberg Traurig, LLP<br> 1750 Tysons Boulevard, Suite 1000<br> McLean, VA 22102<br> (703) 749-1300**

Approximate date of commencement proposed sale to the public: From time to time after the effective date of this Registration Statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.**

**The information in this prospectus is not complete and may be changed. The selling securityholders may not sell the securities until the Registration Statement filed with the Securities and Exchange Commission, of which this prospectus is a part, is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.**

**SUBJECT TO COMPLETION, DATED NOVEMBER 28, 2025**

**Preliminary Prospectus**

**Roadzen Inc.**

**7,946,634 Ordinary Shares**

This prospectus relates to the resale by the selling securityholders of up to an aggregate of 7,946,634 ordinary shares, par value $0.0001 per share (the "Ordinary Shares"), of Roadzen Inc. ("Roadzen," "we," "us" or the "Company"). The number of Ordinary Shares offered for sale by such selling securityholder consists of:

● 90,000 Ordinary Shares issued to FMW Media Works, LLC ("FMW") pursuant to a consulting services agreement dated February 10, 2025

● 80,000 Ordinary Shares issued to Itabira Capital Limited ("Itabira") pursuant to a securities purchase agreement dated May 30, 2025

● 309,567 Ordinary Shares issued to BP Capital Partners, LLC ("BPC") pursuant to a securities purchase agreement dated June 5, 2025;

● 400,000 Ordinary Shares issued to 13books Capital LP ("13books") pursuant to a securities purchase agreement dated June 6, 2025;

● 400,000 Ordinary Shares issued to TLG Fund I, LP ("TLG") pursuant to a securities purchase agreement dated June 10, 2025;

● 309,567 Ordinary Shares issued to Cidel Trust Services Ltd, as the Trustee of the BP Trust ("Cidel") pursuant to a securities purchase agreement dated June 11, 2025;

● 200,000 Ordinary Shares issued to Eugon Investments Limited ("Eugon") pursuant to a securities purchase agreement dated June 26, 2025;

● 1,200,000 Ordinary Shares issued to Pineal Capital Fund I ("Pineal") pursuant to a securities purchase agreement dated October 8, 2025;

● 40,000 Ordinary Shares issued to Outside The Box Capital, Inc. ("OTB") pursuant to a marketing services agreement dated July 21, 2025

● 104,000 Ordinary Shares issued to Avacara PTE, Ltd. ("Avacara") pursuant to a securities purchase agreement dated July 24, 2025;

● 36,000 Ordinary Shares issued to Hudson Global Ventures, LLC. ("Hudson") pursuant to a consulting agreement dated August 8, 2025;

● an aggregate of 3,460,099 Ordinary Shares transferred to certain of the selling securityholders from Vahanna LLC ("Vahanna") pursuant to a pro rata distribution by Vahanna on October 10, 2025;

● 1,317,401 Ordinary Shares issued to Vahanna prior to the Business Combination;

We are registering these shares on behalf of the selling securityholders, to be offered and sold by them from time to time, to satisfy certain registration rights that we have granted to them. The selling securityholders identified in this prospectus, or their transferees, pledgees or donees, or their respective successors, may offer the shares from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. The selling securityholders may resell the shares directly or through one or more underwriters, broker-dealers or agents. For additional information on the methods of sale that may be used by the selling securityholders, see the section entitled "Plan of Distribution" on page 7.

Our registration of the Ordinary Shares covered by this prospectus does not mean that the selling securityholders will offer or sell any of the shares. No underwriter or other person has been engaged to facilitate the sale of the shares in this offering. The selling securityholders will pay or assume discounts, commissions, fees of underwriters, selling brokers or dealer managers and similar expenses, if any, incurred for the sale of our Ordinary Shares.

We may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read the entire prospectus and any amendments or supplements carefully before you make your investment decision.

Our Ordinary Shares and public warrants are listed on The Nasdaq Stock Market under the symbol "RDZN" and "RDZNW," respectively. The last reported sale price of our Ordinary Shares and public warrants on November 26, 2025 was $1.72 and $0.16, respectively.

**Investing in our securities involves certain risks. See the risk factors in our most recent Annual Report on Form 10-K filed on June 26, 2025, as amended, which is incorporated by reference herein, as well as in any other recently filed quarterly or current reports. We urge you to carefully read this prospectus, together with the documents we incorporate by reference, describing the terms of these securities before investing.**

**Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.**

The date of this Prospectus is November 28, 2025

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
|  | **Page** |
| [Cautionary Note Regarding Forward-Looking Statements](#sl_001) | ii |
| [Prospectus Summary](#sl_002) | 1 |
| [The Offering](#sl_003) | 4 |
| [Use of Proceeds](#sl_005) | 5 |
| [Risk Factors](#sl_004) | 5 |
| [Determination of Offering Price](#sl_006) | 5 |
| [Selling Securityholders](#sl_007) | 5 |
| [Plan of Distribution](#sl_008) | 7 |
| [Description of Securities to be Registered](#sl_009) | 8 |
| [Indemnification For Securities Act Liabilities](#sl_010) | 9 |
| [Legal Matters](#sl_011) | 10 |
| [Experts](#sl_012) | 10 |
| [Where You Can Find Additional Information](#sl_013) | 10 |
| [Incorporation of Documents by Reference](#sl_014) | 10 |

---

**You should rely only on the information contained in this prospectus. Neither we nor the selling securityholders have authorized any other person to provide you with information different from or in addition to that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. The selling securityholders are not making an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date.**

**We further note that the representations, warranties and covenants made by us in any document that is filed as an exhibit to the registration statement of which this prospectus is a part and in any document that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.**

In this prospectus, we rely on and refer to information and statistics regarding our industry. We obtained this statistical, market and other industry data and forecasts from publicly available information. While we believe that the statistical data, market data and other industry data and forecasts are reliable, we have not independently verified the data.

This prospectus contains, or incorporates by reference, trademarks, tradenames, service marks and service names of Roadzen Inc. and its subsidiaries. Unless the context otherwise requires, the terms "Roadzen," the "Company," "we," "us," "our" and similar terms used in this prospectus refer to Roadzen Inc.

i

**CAUTIONARY NOTE REGARDING FORWARD LOOKING STATEMENTS**

This prospectus and the documents incorporated by reference herein may contain forward looking statements that involve risks and uncertainties. All statements other than statements of historical fact contained in this prospectus and the documents incorporated by reference herein, including statements regarding future events, our future financial performance, business strategy, and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "should," or "will" or the negative of these terms or other comparable terminology. Although we do not make forward looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks outlined under "Risk Factors" or elsewhere in this prospectus and the documents incorporated by reference herein, which may cause our or our industry's actual results, levels of activity, performance or achievements expressed or implied by these forward-looking statements to differ materially. Moreover, we operate in a highly regulated and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any forward-looking statements.

We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short term and long term business operations, and financial needs. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this prospectus, and in particular, the risks discussed below and under the heading "Risk Factors" and those discussed in other documents we file with the Securities and Exchange Commission, or SEC. The following discussion should be read in conjunction with the financial statements for the fiscal years ended March 31, 2025 and 2024 and notes incorporated by reference therein. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statement.

You should not place undue reliance on any forward-looking statement, each of which applies only as of the date of this prospectus. Except as required by law, we undertake no obligation to update or revise publicly any of the forward-looking statements after the date of this prospectus to conform our statements to actual results or changed expectations.

Any forward-looking statement you read in this prospectus or any document incorporated by reference reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, operating results, growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only as to the date when made. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as otherwise required by applicable law. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Forms 10-Q, 8-K and 10-K filed with the SEC. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.

ii

**PROSPECTUS SUMMARY**

*This summary highlights selected information contained elsewhere in this prospectus. This summary does not contain all the information that you should consider before investing in our Company. You should carefully read the entire prospectus, including all documents incorporated by reference herein. In particular, attention should be directed to our "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and the financial statements and related notes thereto contained herein or otherwise incorporated by reference hereto, before making an investment decision.*

**Overview**

Roadzen has built a pioneering technology platform that uses telematics, computer vision and data science to spearhead innovation across the insurance value chain, namely underwriting, distribution, claims and road safety. We call it the Roadzen "Insurance as a Service" ("IaaS") platform. Our business generates commission-based revenue as an insurance broker focused on embedded and B2B2C (Business-to-Business-to-Customer) insurance distribution, and fee-based revenue as a provider of innovative cloud, telematics, and AI-based applications for the auto insurance ecosystem.

Roadzen has four major client types:

● Insurance — including insurance companies, reinsurers, agents, brokers;

● Automotive — including carmakers, dealerships, online-to-offline car sales platforms;

● Fleets — including small and medium fleets, taxi fleets, ridesharing platforms, commercial and corporate fleets; and

● Other distribution channels such as financial services companies providing auto loans, and telematics companies.

Our operations are global, and our partners consist of market-leading insurance companies, fleets and automotive original equipment manufacturers ("OEMs") and carmakers, including AXA, SCOR, Arch, Société Générale, Jaguar Land Rover, Audi, Mercedes, Volvo and several others. Our subsidiary in the U.K., operates through a specialist Managing General Agent ("MGA") based in Coventry, which provides auto insurance, extended warranties, and claims management services to insurers, automotive dealers, manufacturers, and fleet operators. This MGA leverages its regulatory license to underwrite and service policies locally while utilizing third-party licenses to deliver solutions globally. It acts as a delegated authority on behalf of insurers, managing policy sales and claims adjudication via its brokerage platform. Revenue is generated through commissions and administrative fees tied to Gross Written Premium ("GWP"), with specialty contracts typically structured over five-year terms. Roadzen's subsidiary in the U.S., operates a licensed auto club based in Burlingame, California that specializes in commercial roadside assistance ("RSA") and claims management. With a robust network of over 75,000 service providers nationwide, it offers towing, transportation, and first notice of loss ("FNOL") services to government fleets, enterprises, insurers, and auto manufacturers. These capabilities support our comprehensive suite of mobility and insurance infrastructure services across North America. Roadzen's subsidiary in India operates as a licensed insurance broker providing distribution and servicing of motor insurance products, including RSA, vehicle inspection, and claim facilitation. Our India operations also serve as the company's global technology headquarters, where our product, engineering, and AI teams develop and scale the core platforms that power our insurance and mobility services worldwide. This integrated approach allows us to drive innovation and operational efficiency across all markets we serve.

**Recent Development** 

On October 6, 2025, the Company announced the final closing of its India subsidiary financing, raising $7 million in total, representing approximately 8% dilution at the subsidiary level.

On October 8, 2025, the Company entered into a securities purchase agreements (the "PIPE Purchase Agreement") with an institutional investor (the "PIPE Investor") pursuant to which the Company agreed to issue and sell to the PIPE Investor, and the PIPE Investor agreed to purchase from the Company, an aggregate of 1,200,000 of the Company's Ordinary Shares, for a purchase price of $1.25 per share, or $1,500,000 in the aggregate. Also on October 8, 2025, the Company entered into a registration rights agreement with the PIPE Investor, pursuant to which the Company agreed, among other things, to use its reasonable best efforts to file, on or before December 31, 2025, a registration statement covering the resale of all of the Ordinary Shares sold pursuant to the PIPE Purchase Agreement.

On October 29, 2025, the Company announced it entered into a definitive agreement to acquire majority control of a commercial auto insurance broker and managing general underwriter ("MGU"), licensed to operate as a broker across California, Texas, Illinois and New Jersey, and which also maintains Lloyd's of London Coverholder status, enabling it to underwrite specialty transportation and commercial vehicle risks on behalf of Lloyd's syndicates. The acquired company serves the fast-growing small and mid-sized fleet segment, offering underwriting, claims administration, and distribution through its expanding national agency network. The acquisition is scheduled to close within this quarter, subject to customary closing conditions, at which point Roadzen will exercise board control. Terms of the transaction were not disclosed.

On November 4, 2025, the Company announced it entered into an agreement in principle with Mizuho Securities USA, LLC to extend the maturity date of its senior secured note from December 31, 2025 to June 30, 2027. All other terms remain the same.

**Other Information**

We were incorporated in the British Virgin Islands on April 22, 2021. Roadzen, Inc. ("Roadzen (DE)") was incorporated in the State of Delaware on May 7, 2015. Our principal executive offices are located at 111 Anza Blvd., Suite 109 Burlingame, CA 94010. We also maintain a website at www.roadzen.ai. The information contained in, or that can be accessed through, our website is not part of this prospectus.

**The Offering**

On September 20, 2023, Roadzen Inc. (formerly known as Vahanna Tech Edge Acquisition I Corp, "Roadzen (BVI)"), Roadzen (DE), and Vahanna Merger Sub Corp., a Delaware corporation and a direct, wholly owned subsidiary of Roadzen (BVI) ("Merger Sub"), consummated the business combination pursuant to the Agreement and Plan of Merger, dated February 10, 2023, by and among Roadzen (BVI), Roadzen (DE) and Merger Sub, as amended by the First Amendment to the Agreement and Plan of Merger, dated June 29, 2023 (as so amended, the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into Roadzen (DE), with Roadzen (DE) surviving the merger as a wholly owned subsidiary of Roadzen (BVI) (the "Merger," and together with the other transactions contemplated by the Merger Agreement and the other agreements contemplated thereby, the "Business Combination"). As the accounting acquiror, Roadzen (DE) assumed a non-convertible promissory note amounting to $2.7 million for the benefit of Vahanna, LLC ("Vahanna"). On October 10, 2025, Vahanna transferred 3,460,099 Ordinary Shares to a number of its original investors.

On February 10, 2025, the Company entered into a consulting services agreement with FMW, pursuant to which FMW agreed to offer its services as a consultant to the Company and the Company agreed to issue up to 90,000 Ordinary Shares to FMW as consideration for services rendered under that agreement.

On May 30, 2025, the Company entered into a securities purchase agreement with Itabira. Pursuant to the terms of the securities purchase agreement, on that date, $50,000 in liabilities owed by Vahanna to Itabira was canceled in exchange for the issuance of an aggregate of 40,000 Ordinary Shares, and an additional 40,000 Ordinary Shares were purchased by Itabira. Concurrent with the securities purchase agreement, the Company, Vahanna and Itabira entered into a side letter assigning the debt owed by Vahanna to Itabira to Roadzen, while reducing Roadzen's debt to Vahanna by the same amount.

On June 5, 2025, the Company entered into a securities purchase agreement with BPC. Pursuant to the terms of the securities purchase agreement, on that date, $386,958.60 in liabilities owed by Vahanna to BPC was canceled in exchange for the issuance of an aggregate of 309,567 Ordinary Shares. Concurrent with the securities purchase agreement, the Company, Vahanna and BPC entered into a side letter assigning the debt owed by Vahanna to BPC to Roadzen, while reducing Roadzen's debt to Vahanna by the same amount.

On June 6, 2025, the Company entered into a securities purchase agreement with 13books, whereby 13books agreed to purchase 400,000 Ordinary Shares for a total consideration of $500,000.

On June 10, 2025, the Company entered into a securities purchase agreement with TLG, whereby TLG agreed to purchase 400,000 Ordinary Shares for a total consideration of $500,000.

On June 11, 2025, the Company entered into a securities purchase agreement with Cidel, whereby Cidel agreed to purchase 309,567 Ordinary Shares for a total consideration of $386,958.

On June 26, 2025 the Company entered into a securities purchase agreement with Eugon, whereby Eugon agreed to purchase 200,000 Ordinary Shares for a total consideration of $250,000.

On July 21, 2025, the Company entered into a marketing services agreement with OTB, pursuant to which OTB agreed to offer its services as a consultant to the Company, and the Company agreed to issue up to 40,000 Ordinary Shares as consideration for services rendered. The contract was terminated effective September 10, 2025.

On July 24, 2025, the Company entered into a securities purchase agreement with Avacara. Pursuant to the terms of the securities purchase agreement, on that date, $130,000 in liabilities owed to Avacara was canceled in exchange for the issuance of an aggregate of 104,000 Ordinary Shares.

On August 8, 2025, the Company entered into a consulting agreement with Hudson, pursuant to which Hudson agreed to offer its services as a consultant to the Company, and the Company agreed to issue up to 36,000 Ordinary Shares as consideration for services rendered.

On October 8, 2025, the Company entered into a securities purchase agreement with Pineal, whereby Pineal agreed to purchase 1,200,000 Ordinary Shares for a total consideration of $1,500,000.

On October 10, 2025, Vahanna transferred an aggregate of 3,460,099 Ordinary Shares to its original investors from shares initially issued prior to the Business Combination.

The selling securityholders named in this prospectus may offer and sell up to an aggregate of 7,946,634 Ordinary Shares. The number of Ordinary Shares offered for sale by such selling securityholders consists of (i) 90,000 Ordinary Shares issued to FMW Media Works, LLC pursuant to a consulting services agreement dated February 10, 2025; (ii) 80,000 Ordinary Shares issued to Itabira Capital Limited pursuant to a securities purchase agreement dated May 30, 2025; (iii) 309,567 Ordinary Shares issued to BP Capital Partners, LLC pursuant to a securities purchase agreement dated June 5, 2025; (iv) 400,000 Ordinary Shares issued to 13books Capital LP pursuant to a securities purchase agreement dated June 6, 2025; (v) 400,000 Ordinary Shares issued to TLG Fund I, LP pursuant to a securities purchase agreement dated June 10, 2025; (vi) 309,567 Ordinary Shares issued to Cidel Trust Services Ltd, as the Trustee of the BP Trust pursuant to a securities purchase agreement dated June 11, 2025; (vii) 200,000 Ordinary Shares issued to Eugon Investments Limited pursuant to a securities purchase agreement dated June 26, 2025; (viii) 1,200,000 Ordinary Shares issued to Pineal Capital Fund I pursuant to a securities purchase agreement dated October 8, 2025; (ix) 40,000 Ordinary Shares issued to Outside The Box Capital, Inc. pursuant to a marketing services agreement dated July 21, 2025; (x) 104,000 Ordinary Shares issued to Avacara PTE, Ltd. pursuant to a securities purchase agreement dated July 24, 2025; (xi) 36,000 Ordinary Shares issued to Hudson Global Ventures, LLC. pursuant to a consulting agreement dated August 8, 2025; (xii) an aggregate of 3,460,099 Ordinary Shares transferred to certain of the selling securityholders from Vahanna pursuant to a pro rata distribution by Vahanna on October 10, 2025; and (xiii) 1,317,401 Ordinary Shares issued to Vahanna prior to the Business Combination.

Our Ordinary Shares and public warrants are currently listed on Nasdaq under the symbol "RDZN" and "RDZNW," respectively. We will not receive any of the proceeds of sales by the selling securityholders of any of the shares covered by this prospectus.

When we refer to the "selling securityholder" or "selling shareholders" in this prospectus, we are referring to the holders of the foregoing securities, and their transferees, pledgees or donees, or their respective successors-in-interest that may be identified in a supplement to this prospectus or, if required, a post-effective amendment to the registration statement of which this prospectus is a part.

**THE OFFERING**

---

| | |
|:---|:---|
| **Ordinary Shares offered by the selling securityholders herein:** | 7,946,634 shares |
| **Ordinary Shares outstanding:** | 79,195,068 shares |
| **Use of Proceeds:** | We will not receive any proceeds from the sale of the Ordinary Shares by the selling securityholders. |
| **The Offering Price:** | The selling securityholders may sell all or a portion of their shares through public or private transactions at prevailing market prices or at privately negotiated prices. |
| **The Nasdaq Stock Market Symbol:** | RDZN |
| **Risk Factors:** | An investment in our company is highly speculative and involves a significant degree of risk. See "Risk Factors" and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in shares of our Ordinary Shares. |

---

**RISK FACTORS**

Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider, in addition to the risks and uncertainties discussed above under "Cautionary Note Regarding Forward Looking Statements" above, the risks and uncertainties described under the heading "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 and in any subsequent Quarterly Report on Form 10-Q, as well as those incorporated by reference into this prospectus or any applicable prospectus supplement. You should also carefully consider other information contained and incorporated by reference in this prospectus and any applicable prospectus supplement, including our financial statements and the related notes thereto incorporated by reference in this prospectus. Such risks and uncertainties are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently consider immaterial may also adversely affect us. If any of the described risks occur, our business, financial condition or results of operations could be materially harmed. In such case, the value of our securities could decline and you may lose all or part of your investment.

**USE OF PROCEEDS**

We will not receive any proceeds from the sale of the Ordinary Shares by the selling securityholders.

**DETERMINATION OF OFFERING PRICE**

The selling securityholders will offer Ordinary Shares at the prevailing market prices or a privately negotiated price as they may determine from time to time.

The offering price of our Ordinary Shares to be sold by the selling securityholders do not necessarily bear any relationship to our book value, assets, past operating results, financial condition or any other established criteria of value. The facts considered in determining the offering price were our financial condition and prospects, our limited operating history and the general condition of the securities markets.

In addition, there is no assurance that our Ordinary Shares will trade at market prices in excess of the offering price as prices for Ordinary Shares in any public market will be determined in the marketplace and may be influenced by many factors, including the depth and liquidity.

**SELLING SECURITYHOLDERS**

The following table sets forth certain information as of November 26, 2025 regarding the selling securityholders and the Ordinary Shares currently owned by them and offered by them in this prospectus. Except as indicated in the footnotes to the following table, the selling securityholders named in the table have, based on written representations from the selling securityholders, sole voting and investment power with respect to the shares set forth opposite their names. The percentage of ownership of the selling securityholders in the following table is based upon 79,195,068 Ordinary Shares outstanding as of November 26, 2025. Information with respect to shares beneficially owned prior to the offering includes all shares being offered pursuant to this prospectus.

Other than as described in the footnotes below, none of the selling securityholders or their affiliates has held a position as an officer or director of the Company, nor do the selling securityholders or any of their affiliates have any material relationship of any kind with us or any of our affiliates. All information with respect to share ownership has been furnished by the selling securityholders. The Ordinary Shares being offered is being registered to permit secondary trading of the shares and the selling securityholders may offer all or part of the Ordinary Shares owned for resale from time to time. We cannot advise you as to whether the selling securityholders will in fact sell any or all of such Ordinary Shares. Other than as described in the footnotes below, the selling securityholders do not have any family relationships with our officers, directors or controlling shareholders.

The term "selling securityholders" also includes any transferees, pledgees, donees, or other successors in interest to the selling securityholders named in the table below. To our knowledge, subject to applicable community property laws, each person named in the table has sole voting and investment power with respect to the Ordinary Shares set forth opposite such person's name. We will file a supplement to this prospectus (or a post-effective amendment hereto, if necessary) to name transferees, pledgees, donees or other successors in interest to any named selling securityholders who are able to use this prospectus to resell the securities registered hereby.

The information in the table below and the footnotes thereto regarding Ordinary Shares to be beneficially owned after the offering assumes the sale of all shares being offered by the selling securityholders under this prospectus.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name of Selling Shareholder** | **Number Beneficially Owned Prior to Offering** | **Number Offered Hereby** | **Number Beneficially Owned After Offering** | **Percentage of Class After Offering** |
| FMW Media Works, LLC | 90000 | 90000 |  | \* |
| Itabira Capital Ltd | 249102 | 249102 |  | \* |
| BP Capital Partners, LLC | 309567 | 309567 |  | \* |
| 13books Capital LP | 8096191 | 400000 | 7696191 | 9.7% |
| TLG Fund I, LP | 400000 | 400000 |  | \* |
| Cidel Trust Services Ltd | 309567 | 309567 |  | \* |
| Eugon Investments Ltd. | 402923 | 402923 |  | \* |
| Pineal Capital Fund I | 1200000 | 1200000 |  | \* |
| Outside The Box Capital, Inc. | 40000 | 40000 |  | \* |
| Avacara PTE, Ltd.<sup>(1)</sup> | 17577213 | 104000 | 17473213 | 22.1% |
| Hudson Global Ventures, LLC. | 36000 | 36000 |  | \* |
| Saurav Adhikari | 133464 | 133464 |  | \* |
| Arete Growth Partners, LLC | 84551 | 84551 |  | \* |
| Paul Henry Carlson | 33820 | 33820 |  | \* |
| Vishal Chhibbar | 32497 | 32497 |  | \* |
| El Cano MSF GP, LLC | 926171 | 926171 |  | \* |
| Benjamin Forman | 33820 | 33820 |  | \* |
| Paul S. Galant | 32497 | 32497 |  | \* |
| HVIP Interests LP | 284351 | 284351 |  | \* |
| Richard J. Waters Jr | 169102 | 169102 |  | \* |
| Vatche Keverian | 81243 | 81243 |  | \* |
| Kapil Khetan | 14411 | 14411 |  | \* |
| Mikito Kiname | 32497 | 32497 |  | \* |
| Krishnan-Shah Family Partners, LP<sup>(2)</sup> | 1024858 | 487459 | 537399 | \* |
| Balasubramanian Kalyan Kumar | 4387 | 4387 |  | \* |
| Andrew Douglas Newman | 67641 | 67641 |  | \* |
| OST LLC | 101461 | 101461 |  | \* |
| Muktesh Pant | 81243 | 81243 |  | \* |
| Rahul Puri | 97492 | 97492 |  | \* |
| Rishi Chandna 2014 Separate Property Trust | 32497 | 32497 |  | \* |
| Nerur Shivkumar | 32497 | 32497 |  | \* |
| Bhanu Pratap Singh | 81243 | 81243 |  | \* |
| Aman Sridhar | 16249 | 16249 |  | \* |
| Arun Sinha Revocable Trust | 32497 | 32497 |  | \* |
| Vahanna LLC | 1317401 | 1317401 |  | \* |
| Ashok Vasudevan | 40622 | 40622 |  | \* |
| Meera Vasudevan | 40622 | 40622 |  | \* |
| Sridhar Venkiteswaran | 113740 | 113740 |  | \* |

---

\* Represents beneficial ownership of less than 1%.

(1) Mr. Rohan Malhotra, the Chief Executive Officer and a director of the Company, is the majority shareholder and managing director of Avacara, a Singapore corporation with offices located at 14 Robinson Road, #12-01/02, Far East Finance Building, Singapore, 048545.

(2) Ajay Shah, a director of the Company, and his wife, are trustees of the general partner of Krishnan-Shah. The shares reported under "Number Beneficially Owned Prior to the Offering" consist of 487,399 Ordinary Shares as reported in Form 4 filed by Ajay Shah on December 15, 2023, 50,000 Ordinary Shares issuable upon exercise of the warrants issued pursuant to the March 2024 SPA and 487,459 Ordinary Shares transferred by Vahanna.

**PLAN OF DISTRIBUTION**

We are registering the resale by the selling securityholders of up to 7,946,634 Ordinary Shares.

The securities beneficially owned by the selling securityholders covered by this prospectus may be offered and sold from time to time by the selling securityholders. The term "selling securityholders" includes donees, pledgees, transferees or other successors in interest selling securities received after the date of this prospectus from selling securityholders as a gift, pledge, partnership distribution or other transfer. The selling securityholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then-current market price or in negotiated transactions. The selling securityholders may dispose of their securities by one or more of, or a combination of, the following methods:

● distributions to members, partners, shareholders or other equityholders of the selling securityholders;

● purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus;

● ordinary brokerage transactions and transactions in which the broker solicits purchasers;

● block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;

● an over-the-counter distribution in accordance with the rules of the Nasdaq;

● through trading plans entered into by selling securityholders pursuant to Rule 10b5-1 under the Exchange Act, that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans;

● to or through underwriters or broker-dealers;

● in "at the market" offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents;

● in privately negotiated transactions;

● in options transactions;

● through a combination of any of the above methods of sale; or

● any other method permitted pursuant to applicable law.

In addition, any securities that qualify for sale pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to this prospectus. A selling securityholder that is an entity may elect to make an in-kind distribution of ordinary shares to its members, partners, shareholders or other equityholders pursuant to the registration statement of which this prospectus forms a part by delivering a prospectus. To the extent that such members, partners, shareholders or other equityholders are not affiliates of ours, such members, partners, shareholders or other equityholders would thereby receive freely tradable securities pursuant to a distribution pursuant to the registration statement of which this prospectus forms a part.

To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of the securities or otherwise, the selling securityholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of securities in the course of hedging the positions they assume with selling securityholders. The selling securityholders may also sell the securities short and redeliver the securities to close out such short positions. The selling securityholders may also enter into option or other transactions with broker-dealers or other financial institutions that require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction). The selling securityholders may also pledge securities to a broker-dealer or other financial institution, and, upon a default, such broker-dealer or other financial institution, may effect sales of the pledged securities pursuant to this prospectus (as supplemented or amended to reflect such transaction).

A selling securityholder may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by any selling securityholder or borrowed from any selling securityholder or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from any selling securityholder in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and will be identified in the applicable prospectus supplement (or a post-effective amendment). In addition, any selling securityholder may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.

In effecting sales, broker-dealers or agents engaged by the selling securityholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling securityholders in amounts to be negotiated immediately prior to the sale.

In offering the securities covered by this prospectus, the selling securityholders and any broker-dealers who execute sales for the selling securityholders may be deemed to be "underwriters" within the meaning of the Securities Act in connection with such sales. Any profits realized by the selling securityholders and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions.

In order to comply with the securities laws of certain states, if applicable, the securities must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the securities may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

We have advised the selling securityholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of securities in the market and to the activities of the selling securityholders and their affiliates. In addition, we will make copies of this prospectus available to the selling securityholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling securityholders may indemnify any broker-dealer that participates in transactions involving the sale of the securities against certain liabilities, including liabilities arising under the Securities Act.

At the time a particular offer of securities is made, if required, a prospectus supplement will be distributed that will set forth the number of securities being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public.

**DESCRIPTION OF SECURITIES TO BE REGISTERED**

**General**

Roadzen is a BVI business company limited by shares and its affairs is governed by its Memorandum and Articles of Association and the BVI Companies Act (each as amended or modified from time to time). As provided in the Memorandum and Articles of Association, subject to the BVI Companies Act, Roadzen has full capacity to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers and privileges. The registered office of Roadzen is c/o Maples Corporate Services Limited, Kingston Chambers, P.O. Box 173, Road Town, Tortola, British Virgin Islands.

The authorized shares of Roadzen consists of 220,000,000 Ordinary Shares and 60,000,000 preference shares, par value $0.0001 per share ("Preference Shares").

**Ordinary Shares**

Each Ordinary Share confers upon the shareholder:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. the right to one vote at a meeting of the Roadzen shareholders or on any resolution of the Roadzen shareholders;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. subject to any rights that may be granted to holders of Preference Shares in the future, the right to an equal share in any distribution paid by Roadzen in accordance with the BVI Companies Act; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. subject to any rights that may be granted to holders of Roadzen Preference Shares in the future, the right to an equal share in the distribution of the surplus assets of Roadzen on its liquidation in accordance with the BVI Companies Act.

Ordinary Shares have the same rights and privileges and rank equally, share ratably and be identical in all respect to all matters.

**Transfer Agent and Registrar**

The transfer agent and registrar for our Ordinary Shares is Continental Stock Transfer & Trust Company, located at One State Street Plaza, 30th Floor, New York, New York 10004.

**Listing**

Roadzen's Ordinary Shares are listed and traded on Nasdaq under the trading symbol "RDZN."

**INDEMNIFICATION OF OFFICERS AND DIRECTORS**

Subject to the provisions of the BVI Companies Act, the Amended and Restated Memorandum and Articles of Association of Roadzen provides that Roadzen may indemnify against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings any person who:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings, whether civil, criminal, administrative or investigative, by reason of the fact that the person is or was a director of Roadzen; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) is or was, at the request of Roadzen, serving as a director of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise.

Pursuant to the BVI Companies Act, the indemnity applies only to a person who has acted honestly and in good faith and in what he believed to be the best interests of Roadzen and, in the case of criminal proceedings, provided the person had no reasonable cause to believe that his conduct was unlawful. The Registrant shall not indemnify a person who has not so acted, and any indemnity given to such a person is void and of no effect.

The termination of any proceedings by any judgement, order, settlement, conviction or the entering of a nolle prosequi does not, by itself, create a presumption that the person did not act honestly and in good faith and with a view to the best interests of Roadzen or that the person had reasonable cause to believe that his conduct was unlawful.

Expenses, including legal fees, incurred by a director in defending any legal, administrative or investigative proceedings may be paid by Roadzen in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the director to repay the amount if it shall ultimately be determined that the director is not entitled to be indemnified by Roadzen in accordance with the Amended and Restated Memorandum and Articles of Association.

Expenses, including legal fees, incurred by a former director in defending any legal, administrative or investigative proceedings may be paid by Roadzen in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the former director to repay the amount if it shall ultimately be determined that the former director is not entitled to be indemnified by Roadzen in accordance with the Amended and Restated Memorandum and Articles of Association and upon such other terms and conditions, if any, as Roadzen deems appropriate.

The indemnification and advancement of expenses provided by, or granted pursuant to, the Amended and Restated Memorandum and Articles of Association is not exclusive of any other rights to which the person seeking indemnification or advancement of expenses may be entitled under any agreement, resolution of members, resolution of disinterested directors or otherwise, both as to acting in the person's official capacity and as to acting in another capacity while serving as a director of Roadzen.

The Registrant may purchase and maintain insurance in relation to any person who is or was a director of Roadzen, or who at the request of Roadzen is or was serving as a director of, or in any other capacity is or was acting for, another body corporate or a partnership, joint venture, trust or other enterprise, against any liability asserted against the person and incurred by the person in that capacity, whether or not Roadzen has or would have had the power to indemnify the person against the liability under the Amended and Restated Memorandum and Articles of Association.

In addition, Roadzen may maintain standard policies of insurance under which coverage is provided to its directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act, and to Roadzen with respect to payments which may be made by Roadzen to such directors and officers pursuant to the above indemnification provision or otherwise as a matter of law.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

**LEGAL MATTERS**

Unless otherwise indicated in the applicable prospectus supplement, the validity of the securities offered by this prospectus were passed upon for us by Maples & Calder.

**EXPERTS**

The consolidated financial statements of Roadzen Inc. as of March 31, 2025 and 2024, and for each of the years in the two-year period ended March 31, 2025, have been incorporated by reference herein in reliance upon the report of ASA & Associates LLP, an independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

**WHERE YOU CAN FIND ADDITIONAL INFORMATION**

We file annual, quarter and periodic reports, proxy statements and other information with the Securities and Exchange Commission using the Commission's EDGAR system. The Commission maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the Commission. The address of such site is http//www.sec.gov.

We have filed a registration statement with the Commission relating to the offering of the shares. The registration statement contains information which is not included in this prospectus. You may inspect or copy the registration statement at the Commission's public reference facilities or its website.

You should rely only on the information contained in this prospectus. We have not authorized any person to provide you with any information that is different.

**INCORPORATION OF DOCUMENTS BY REFERENCE**

We are "incorporating by reference" in this prospectus certain documents we file with the SEC, which means that we can disclose important information to you by referring you to those documents. The information in the documents incorporated by reference is considered to be part of this prospectus. Statements contained in documents that we file with the SEC and that are incorporated by reference in this prospectus will automatically update and supersede information contained in this prospectus, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. We have filed or may file the following documents with the SEC and they are incorporated herein by reference as of their respective dates of filing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. our Quarterly Report on [Form 10-Q](https://www.sec.gov/Archives/edgar/data/1868640/000149315225022583/form10-q.htm) for the six months ended September 30, 2025, filed with the SEC on November 14, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. our Quarterly Report on [Form 10-Q](https://www.sec.gov/Archives/edgar/data/1868640/000164117225023491/form10-q.htm) for the three months ended September 30, 2025, filed with the SEC on August 13, 2025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. our Annual Report on [Form 10-K](https://www.sec.gov/Archives/edgar/data/1868640/000164117225016647/form10-k.htm) for the fiscal year ended March 31, 2025, filed with the SEC on June 26, 2025, as amended by the [Form 10-K/A](https://www.sec.gov/Archives/edgar/data/1868640/000149315225024374/form10-ka.htm) filed with the SEC on November 20, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. our Current Reports on Form 8-K filed with the SEC on [April 1, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225002155/form8-k.htm), [April 2, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225002387/form8-ka.htm), [April 3, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225002579/form8-k.htm), [April 21, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225005571/form8-k.htm), [June 26, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225016641/form8-k.htm), [July 30, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021507/form8-k.htm), [July 31, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021773/form8-k.htm), [August 13, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225023483/form8-k.htm), [October 29, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000149315225020060/form8-k.htm), [November 4, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000149315225020690/form8-k.htm), [November 14, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000149315225022601/form8-k.htm) and [November 20, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000149315225024501/form8-k.htm); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. the description of our capital stock contained in our registration statement on [Form 8-A](https://www.sec.gov/Archives/edgar/data/1868640/000119312521334628/d255702d8a12b.htm) (File No. 001-41094) filed on November 19, 2021, and any amendments or reports filed for the purposes of updating this description.

We incorporate by reference any additional filings made by us with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 (other than the portions of those made pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information "furnished" to the SEC) after the filing of the initial registration statement (including all such documents that we may file with the SEC after the date the registration statement was initially filed and prior to the effectiveness of the registration statement) and before the filing of a post-effective amendment to the registration statement of which this prospectus is a part that indicates that all securities offered hereunder have been sold or that deregisters all securities then remaining unsold (other than information furnished and not filed with the SEC). These documents may include periodic reports, like Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as Proxy Statements. Any material that we subsequently file with the SEC will automatically update and replace the information previously filed with the SEC.

Any statement contained in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed modified, superseded or replaced for purposes of this prospectus to the extent that a statement contained in this prospectus, or in any subsequently filed document that also is deemed to be incorporated by reference in this prospectus, modifies, supersedes or replaces such statement. Any statement so modified, superseded or replaced shall not be deemed, except as so modified, superseded or replaced, to constitute a part of this prospectus. None of the information that we disclose under Items 2.02 or 7.01 of any Current Report on Form 8-K or any corresponding information, either furnished under Item 9.01 or included as an exhibit therein, that we may from time to time furnish to the SEC will be incorporated by reference into, or otherwise included in, this prospectus, except as otherwise expressly set forth in the relevant document. Subject to the foregoing, all information appearing in this prospectus is qualified in its entirety by the information appearing in the documents incorporated by reference.

You may request, orally or in writing, a copy of these documents, which will be provided to you at no cost (other than exhibits, unless such exhibits are specifically incorporate by reference), by contacting Roadzen Inc., 111 Anza Blvd, Suite 109, Burlingame, California 94010, or by telephone at (650) 414-3530. Information about us is also available at our website at www.roadzen.ai. However, the information in our website is not a part of this prospectus and is not incorporated by reference.

**ROADZEN INC.**

**7,946,634 Ordinary Shares**

**PROSPECTUS**

**PART II**

**INFORMATION NOT REQUIRED IN PROSPECTUS**

**Item 14. Other Expenses of Issuance and Distribution.**

The Company is paying all expenses of the offering. No portion of these expenses will be borne by the selling security holder. The selling security holder, however, will pay any other expenses incurred in selling its Ordinary Shares, including any brokerage commissions or costs of sale. Following is an itemized statement of all expenses in connection with this registration statement. All of the amounts shown are estimates, except for the SEC Registration Fees.

---

| | |
|:---|:---|
| SEC registration fee | $1646.15 |
| Printing | 5000.0 \* |
| Legal fees and expenses | $10000.0 \* |
| Accounting fees and expenses | $5000.0 \* |
| Miscellaneous | 5000.0 \* |
| Total | $26646.15 \* |

---

\* These fees are estimated and accordingly are subject to change.

**Item 15. Indemnification of Directors and Officers.**

Subject to the provisions of the BVI Companies Act, the Amended and Restated Memorandum and Articles of Association of Roadzen provides that Roadzen may indemnify against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings any person who:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings, whether civil, criminal, administrative or investigative, by reason of the fact that the person is or was a director of Roadzen; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) is or was, at the request of Roadzen, serving as a director of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise.

Pursuant to the BVI Companies Act, the indemnity applies only to a person who has acted honestly and in good faith and in what he believed to be the best interests of Roadzen and, in the case of criminal proceedings, provided the person had no reasonable cause to believe that his conduct was unlawful. The Registrant shall not indemnify a person who has not so acted, and any indemnity given to such a person is void and of no effect.

The termination of any proceedings by any judgement, order, settlement, conviction or the entering of a nolle prosequi does not, by itself, create a presumption that the person did not act honestly and in good faith and with a view to the best interests of Roadzen or that the person had reasonable cause to believe that his conduct was unlawful.

Expenses, including legal fees, incurred by a director in defending any legal, administrative or investigative proceedings may be paid by Roadzen in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the director to repay the amount if it shall ultimately be determined that the director is not entitled to be indemnified by Roadzen in accordance with the Amended and Restated Memorandum and Articles of Association.

Expenses, including legal fees, incurred by a former director in defending any legal, administrative or investigative proceedings may be paid by Roadzen in advance of the final disposition of such proceedings upon receipt of an undertaking by or on behalf of the former director to repay the amount if it shall ultimately be determined that the former director is not entitled to be indemnified by Roadzen in accordance with the Amended and Restated Memorandum and Articles of Association and upon such other terms and conditions, if any, as Roadzen deems appropriate.

The indemnification and advancement of expenses provided by, or granted pursuant to, the Amended and Restated Memorandum and Articles of Association is not exclusive of any other rights to which the person seeking indemnification or advancement of expenses may be entitled under any agreement, resolution of members, resolution of disinterested directors or otherwise, both as to acting in the person's official capacity and as to acting in another capacity while serving as a director of Roadzen.

The Registrant may purchase and maintain insurance in relation to any person who is or was a director of Roadzen, or who at the request of Roadzen is or was serving as a director of, or in any other capacity is or was acting for, another body corporate or a partnership, joint venture, trust or other enterprise, against any liability asserted against the person and incurred by the person in that capacity, whether or not Roadzen has or would have had the power to indemnify the person against the liability under the Amended and Restated Memorandum and Articles of Association.

In addition, Roadzen may maintain standard policies of insurance under which coverage is provided to its directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act, and to Roadzen with respect to payments which may be made by Roadzen to such directors and officers pursuant to the above indemnification provision or otherwise as a matter of law.

**Item 16. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description of Document** |
| 3.1<sup>(1)</sup> | [Amended and Restated Memorandum and Articles of Roadzen Inc.](https://www.sec.gov/Archives/edgar/data/1868640/000119312523242523/d537808dex31.htm) |
| 4.1<sup>(2)</sup> | [Warrant Agreement, dated November 22, 2021.](https://www.sec.gov/Archives/edgar/data/1868640/000119312521342437/d244497dex41.htm) |
| 4.2<sup>(1)</sup> | [Form of Specimen Ordinary Shares Certificate of Roadzen Inc.](https://www.sec.gov/Archives/edgar/data/1868640/000119312523242523/d537808dex41.htm) |
| 4.2<sup>(3)</sup> | [Form of Convertible Debenture](https://www.sec.gov/Archives/edgar/data/1868640/000095017024006964/rdzn-ex4_1.htm) |
| 4.3<sup>(1)</sup> | [Form of Warrant Certificate of Roadzen, Inc.](https://www.sec.gov/Archives/edgar/data/1868640/000119312523242523/d537808dex42.htm) |
| 10.1<sup>(4)</sup> | [Form of Placement Agency Agreement, dated July 27, 2025](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021773/ex10-1.htm) |
| 10.2<sup>(4)</sup> | [Form of Securities Purchase Agreement, dated as of July 27, 2024](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021773/ex10-2.htm) |
| 10.3<sup>(5)</sup> | [Form of Securities Purchase Agreement](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021507/ex10-1.htm) |
| 10.4<sup>(5)</sup> | [Form of Registration Rights Agreement.](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021507/ex10-2.htm) |
| 10.5<sup>(5)</sup> | [Form of Amendment to Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement.](https://www.sec.gov/Archives/edgar/data/1868640/000164117225021507/ex10-3.htm) |
| 10.6<sup>(6)</sup> | [Securities Purchase Agreement, dated March 31, 2025.](https://www.sec.gov/Archives/edgar/data/1868640/000164117225002155/ex10-1.htm) |
| 10.7<sup>(6)</sup> | [Form of Junior Convertible Note.](https://www.sec.gov/Archives/edgar/data/1868640/000164117225002155/ex10-2.htm) |
| 5.1 | [Opinion of Maples & Calder\*](ex5-1.htm) |
| 23.1 | [Consent of ASA & Associates LLP \*](ex23-1.htm) |
| 23.2 | [Consent of Maples & Calder (included in Exhibit 5.1)\*](ex5-1.htm) |
| 24.1 | [Power of Attorney (included in Part II of this Registration Statement)](#p_001) |
| 107 | [Filing Fee Table\*](ex107.htm) |

---

The following exhibits are filed with this Registration Statement.

\* Filed herewith.

(1) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on September 26, 2023.

(2) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on November 29, 2021.

(3) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on January 24, 2024.

(4) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on July 31, 2025.

(5) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on J uly 30, 2025.

(6) Incorporated by reference to an exhibit to the Company's current
 report on Form 8-K filed with the SEC on April 1, 2025.

**Item 17. Undertakings.**

The undersigned registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

*provided*, *however*, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) If the registrant is relying on Rule 430B:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) The undersigned registrant hereby undertakes that, for purposes of determining any liability of the registrant under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) The undersigned registrant hereby undertakes to supplement the prospectus, after the expiration of the subscription period, to set forth the results of the subscription offer, the transactions by the underwriters during the subscription period, the amount of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent reoffering thereof. If any public offering by the underwriters is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective amendment will be filed to set forth the terms of such offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) The undersigned registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Trust Indenture Act.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Burlingame, State of California, on this 28th day of November, 2025.

---

| | |
|:---|:---|
| **Roadzen Inc.** | **Roadzen Inc.** |
|  | */s/ Rohan Malhotra* |
| Name: | Rohan Malhotra |
| Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY**

**KNOW ALL PERSONS BY THESE PRESENTS**, that each person whose signature appears below does hereby constitute and appoint Rohan Malhotra and Jean-Noël Gallardo and each of them, with full power of substitution, such person's true and lawful attorneys-in-fact and agents for such person, with full power and authority to do any and all acts and things and to execute any and all instruments which said attorneys and agents, and any one of them, determine may be necessary or advisable or required to enable said corporation to comply with the Securities Act of 1933, as amended, and any rules or regulations or requirements of the Securities and Exchange Commission in connection with this Registration Statement. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to this Registration Statement, to any and all amendments, both pre-effective and post-effective, and supplements to this Registration Statement, and to any and all instruments or documents filed as part of or in conjunction with this Registration Statement or amendments or supplements thereof, and each of the undersigned hereby ratifies and confirms that all said attorneys and agents, or any one of them, shall do or cause to be done by virtue hereof. This Power of Attorney may be signed in several counterparts.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Rohan Malhotra* | Chief Executive Officer and Director | November 28, 2025 |
| Rohan Malhotra | (Principal Executive Officer) |  |
| */s/ Jean-Noël Gallardo* | Chief Financial Officer | November 28, 2025 |
| Jean-Noël Gallardo | (Principal Financial and Accounting Officer) |  |
| */s/ Steven Carlson* | Chairman and Director | November 28, 2025 |
| Steven Carlson |  |  |
| */s/ Saurav Adhikari* | Director | November 28, 2025 |
| Saurav Adhikari |  |  |
| */s/ Ajay Shah* | Director | November 28, 2025 |
| Ajay Shah |  |  |
| */s/ Supurna VedBrat* | Director | November 28, 2025 |
| Supurna VedBrat |  |  |
| */s/ Zoë Ashcroft* | Director | November 28, 2025 |
| Zoë Ashcroft |  |  |
| */s/ Diane B. Glossman* | Director | November 28, 2025 |
| Diane B. Glossman |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

Our ref: CHX/787490-000017/41617945v4

Roadzen Inc. Kingston Chambers P.O. Box 173 Road Town, Tortola British Virgin Islands

28 November 2025

Dear Sirs

**Roadzen Inc. (the "Company")**

We have acted as counsel as to British Virgin Islands law to the Company in respect of the proposed resale of an aggregate of 7,946,634 ordinary shares in the Company with a par value of US$0.0001 each (the "**Ordinary Shares**") to the Selling Securityholders (as defined in the Registration Statement) consisting of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) 90,000
 Ordinary Shares issued to FMW Media Works, LLC ()"**FMW**") pursuant to a consulting services agreement dated 10 February
 2025 between the Company and FMW, as amended by a first amendment dated 14 October 2025 (the "**FMW Agreement** ");

(b) 80,000
 Ordinary Shares issued to Itabira Capital Limited ()"**Itabira**") pursuant to a securities purchase agreement dated
 30 May 2025 between the Company and Itabira, together with a side letter dated 6 June 2025 (the "**Itabira Agreement** ");

(c) 309,567
 Ordinary Shares issued to BP Capital Partners, LLC ()"**BPC**") pursuant to a securities purchase agreement dated 5
 June 2025 between the Company and BPC, together with a side letter dated 5 June 2025 (the "**BPC Agreement** ");

(d) 400,000
 Ordinary Shares issued to 13books Capital LP ()"**13books**") pursuant to a securities purchase agreement dated 6 June
 2025 between the Company and 13books (the "**13books Agreement** ");

(e) 400,000
 Ordinary Shares issued to TLG Fund I, LP ()"**TLG**") pursuant to a securities purchase agreement dated 10 June 2025
 between the Company and TLG (the "**TLG Agreement** ");

(f) 309,567
 Ordinary Shares issued to Cidel Trust Services Ltd, as the Trustee of the BP Trust ()"**Cidel'**) pursuant to a securities
 purchase agreement dated 11 June 2025 between the Company and Cidel (the "**Cidel Agreement** ");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) 200,000
 Ordinary Shares issued to Eugon Investments Limited ()"**Eugon**") pursuant to a securities purchase agreement dated
 26 June 2025 between the Company and Eugon (the "**Eugon Agreement** ");

(h) 1,200,000
 Ordinary Shares issued to Pineal Capital Fund I ()"**Pineal**") pursuant to a securities purchase agreement dated 8
 October 2025 between the Company and Pineal (the "**Pineal Agreement** ");

(i) 40,000
 Ordinary Shares issued to Outside The Box Capital, Inc. ()"**OTB**") pursuant to a marketing services agreement dated
 21 June 2025 between the Company and OTB (the "**OTB Agreement** ");

(j) 104,000
 Ordinary Shares issued to Avacara PTE, Ltd. ()"**Avacara**") pursuant to a securities purchase agreement dated 24 July
 2025 between the Company and Avacara (the "**Avacara Agreement** ");

(k) 36,000
 Ordinary Shares to Hudson Global Ventures, LLC. ()"**Hudson**") pursuant to a consulting agreement dated 8 August 2025
 between the Company and Hudson (the "**Hudson Agreement** ");

(l) 133,464
 Ordinary Shares issued to Vahanna LLC ()"**Vahanna**") under the subscription agreement dated 6 May 2021 made between
 the Company and Vahanna in respect of the purchase of 5,750,000 shares in the Company (the "**Sponsor Subscription Agreement** ")
 and transferred to Saurav Adhikari on 10 October 2025;

(m) 84,551
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Arete Growth Partners, LLC on 10 October
 2025;

(n) 33,820
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Paul Henry Carlson on 10 October 2025;

(o) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Vishal Chhibbar on 10 October 2025;

(p) 926,171
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to El Cano MSF GP, LLC on 10 October 2025;

(q) 202,923
 Ordinary Shares transferred to Eugon Investments Ltd. by Vahanna on October 10, 2025, from shares issued to Vahanna prior to the
 Business Combination;

(r) 33,820
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Benjamin Forman on 10 October 2025;

(s) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Paul S. Galant on 10 October 2025;

(t) 284,351
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to HVIP Interests LP on 10 October 2025;

(u) 169,102
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Itabira Capital Ltd on 10 October 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) 169,102
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Richard J. Waters Jr on 10 October
 2025;

(w) 81,243
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Vatche Keverian on 10 October 2025;

(x) 14,411
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Kapil Khetan on 10 October 2025;

(y) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Mikito Kiname on 10 October 2025;

(z) 487,459
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Krishnan-Shah Family Partners, LP on
 10 October 2025;

(aa) 4,387
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Balasubramanian Kalyan Kumar on 10
 October 2025;

(bb) 67,641
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Andrew Douglas Newman on 10 October
 2025;

(cc) 101,461
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to OST LLC on 10 October 2025;

(dd) 81,243
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Muktesh Pant on 10 October 2025;

(ee) 97,492
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Rahul Puri on 10 October 2025;

(ff) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Rishi Chandna 2014 Separate Property
 Trust on 10 October 2025;

(gg) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Nerur Shivkumar 2014 Separate Property
 Trust on 10 October 2025;

(hh) 81,243
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Bhanu Pratap Singh on 10 October 2025;

(ii) 16,249
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Aman Sridhar on 10 October 2025;

(jj) 32,497
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Arun Sinha Revocable Trust on 10 October
 2025;

(kk) 1,317,401
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement;

(ll) 40,622
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Ashok Vasudevan on 10 October 2025;

(mm) 40,622
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Meera Vasudevan on 10 October 2025;
 and

(nn) 113,740
 Ordinary Shares issued to Vahanna under the Sponsor Subscription Agreement and transferred to Sridhar Venkiteswaran on 10 October
 2025.

We have been asked to provide this legal opinion in connection with the Company's registration statement on amendment no. 1 to Form S-3 dated 26 November 2025, including all amendments or supplements thereto filed with the United States Securities and Exchange Commission (the "Commission") under the United States Securities Act of 1933, as amended (the "**SEC Act**") (the "Registration Statement").

---

| | |
|:---|:---|
| **1** | **Documents Reviewed** |

---

We have reviewed originals, copies, drafts or conformed copies of the following documents:

1.1 The
 public records of the Company on file and available for public inspection at the Registry of Corporate Affairs in the British Virgin
 Islands (the "**Registry of Corporate Affairs**") on 28 November 2025, including the Company's Certificate
 of Incorporation and its Memorandum and Articles of Association (the "**Memorandum and Articles** ").

1.2 A
 list of the Company's directors provided by the Registry of Corporate Affairs dated 19 November 2025 (the "**Registry List of Directors** ").

1.3 The
 records of proceedings available from a search of the electronic records maintained on the Judicial Enforcement Management System
 and the E-Litigation Portal from 1 January 2000 and available for inspection on 28 November 2025 at the British Virgin Islands
 High Court Registry (the "**High Court Registry** ").

1.4 The
 written resolutions of the board of directors passed on 6 May 2021, 28 October 2021, 22 November 2021, 27 May 2025, 15 October 2025
 and 22 November 2025 and the written resolutions of the members of the committee dated 24 July 2025 (together, the "**Resolutions** ").

1.5 A
 Certificate of Incumbency dated 19 November 2025, issued by Maples Corporate Services (BVI) Limited, the Company's registered
 agent (the "**Registered Agent's Certificate** ").

1.6 A
 certificate of good standing with respect to the Company issued by the Registrar of Corporate Affairs dated 19 November 2025 (the
 "**Certificate of Good Standing** ").

1.7 A
 certificate from a director of the Company (the "**Director's Certificate** "), a copy of which is appended to
 this opinion at Appendix A.

1.8 The
 FMW Agreement.

1.9 The
 Itabira Agreement.

1.10 The
 BPC Agreement.

1.11 The
 13books Agreement.

1.12 The
 TLG Agreement.

1.13 The
 Cidel Agreement.

1.14 The
 Eugon Agreement.

1.15 The
 Pineal Agreement.

1.16 The
 OTB Agreement.

1.17 The
 Avacara Agreement.

1.18 The
 Hudson Agreement.

1.19 The
 Sponsor Subscription Agreement.

The documents listed in paragraphs 1.8 to 1.19 inclusive above shall be referred to collectively herein as the "**Documents**".

---

| | |
|:---|:---|
| **2** | **Assumptions** |

---

The following opinions are given only as to, and based on, circumstances and matters of fact existing and known to us on the date of this opinion letter. These opinions only relate to the laws of the British Virgin Islands which are in force on the date of this opinion letter. In giving the following opinions we have relied (without further verification) upon the completeness and accuracy, as at the date of this opinion letter, of the Registry List of Directors, the Registered Agent's Certificate, the Certificate of Good Standing and the Director's Certificate. We have also relied upon the following assumptions, which we have not independently verified:

2.1 The
 Documents have been or will be authorised and duly executed and unconditionally delivered by or on behalf of all relevant parties
 in accordance with all relevant laws (including, without limitation, the laws of the British Virgin Islands).

2.2 The
 Documents are, or will be, legal, valid, binding and enforceable against all relevant parties in accordance with its terms under
 all relevant laws (including, without limitation, the laws of the British Virgin Islands).

2.3 Copies
 of documents, conformed copies or drafts of documents provided to us are true and complete copies of, or in the final forms of, the
 originals.

2.4 All
 signatures, initials and seals are genuine.

2.5 That
 all public records of the Company which we have examined are accurate and that the information disclosed by the searches which we
 conducted against the Company at the Registry of Corporate Affairs and the High Court Registry is true and complete and that such
 information has not since then been altered and that such searches did not fail to disclose any information which had been delivered
 for registration but did not appear on the public records at the date of our searches.

2.6 The
 Memorandum and Articles remain in full force and effect and are unamended and that there are a sufficient number of authorised shares
 to allow for the issuance of the Ordinary Shares.

2.7 The
 Resolutions were each signed by all the directors in the manner prescribed in the Memorandum and Articles of the Company, including
 as to the disclosure of any director's interests, and have not been amended, varied or revoked in any respect.

2.8 The
 members of the Company (the "**Members**") have not restricted or limited the powers of the directors of the Company
 in any way.

2.9 No
 invitation has been or will be made by or on behalf of the Company to the public in the British Virgin Islands to subscribe for any
 of the Ordinary Shares.

2.10 The
 Ordinary Shares issued pursuant to the Documents have been, or will be, duly registered, and will continue to be registered, in the
 Company's register of members.

2.11 The
 Company has received, or will receive, cash consideration or non-cash consideration in consideration for the issue of the Ordinary
 Shares, and that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) none
 of the Ordinary Shares have been, or will be, issued for less than their par value; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) to
 the extent that any Ordinary Shares are, or will be, issued, in whole or in part, for non-cash consideration, the value of the non-cash
 consideration and cash consideration, if any, is not less than the amount credited or to be credited for such Ordinary Shares.

2.12 The
 issue of the Ordinary Shares to the Selling Securityholders by the Company as contemplated by the Documents, as applicable, was authorised
 and such Ordinary Shares were legally issued, fully paid and non-assessable (as a matter of all relevant laws, other than the laws
 of the British Virgin Islands) and all conditions to the issuance of the Ordinary Shares pursuant to the Documents were satisfied.

2.13 There
 is nothing under any law (other than the laws of the British Virgin Islands) which would or might affect the opinions set out below.

Save as aforesaid we have not been instructed to undertake and have not undertaken any further enquiry or due diligence in relation to the transaction the subject of this opinion.

---

| | |
|:---|:---|
| **3** | **Opinions** |

---

Based upon, and subject to, the foregoing assumptions and the qualifications set out below, and having regard to such legal considerations as we deem relevant, we are of the opinion that:

3.1 The
 Ordinary Shares held by the Selling Securityholders to be resold as contemplated by the Registration Statement have been duly authorised
 for issue, and when issued and paid for in the manner described in the Documents and in accordance with the Resolutions, such Ordinary
 Shares will be validly issued, fully paid and non-assessable. As a matter of British Virgin Islands law, a share is only issued when
 it has been entered in the register of members of the Company.

---

| | |
|:---|:---|
| **4** | **Qualifications** |

---

The opinions expressed above are subject to the following qualifications:

4.1 We
 have not reviewed the Documents save as expressly referred to in paragraph 3.1 of this opinion and our opinions are qualified accordingly.

4.2 We
 express no view as to the commercial terms of the Documents or whether such terms represent the intentions of the parties and we
 make no comment with respect to any representations and warranties which may be made by or with respect to the Company in any of
 the documents or instruments cited in this opinion or otherwise with respect to the commercial terms of the transactions the subject
 of this opinion.

4.3 Under
 British Virgin Islands law, the register of members is *prima facie* evidence of title to shares and this register would not
 record a third party interest in such shares. However, there are certain limited circumstances where an application may be made to
 a British Virgin Islands court for a determination on whether the register of members reflects the correct legal position. Further,
 the British Virgin Islands court has the power to order that the register of members maintained by a company should be rectified
 where it considers that the register of members does not reflect the correct legal position. For the purposes of the opinion given
 in paragraph 3.1, there are no circumstances or matters of fact known to us on the date of this opinion letter which would properly
 form the basis for an application for an order for rectification of the register of members of the Company, but if such an application
 were made in respect of the Ordinary Shares, then the validity of such shares may be subject to re-examination by a British Virgin
 Islands court.

4.4 Except
 as specifically stated herein, we make no comment with respect to any representations and warranties which may be made by or with
 respect to the Company in any of the documents or instruments cited in this opinion or otherwise with respect to the commercial terms
 of the transactions the subject of this opinion.

4.5 In
 this opinion letter, the phrase "non-assessable" means, with respect to the issuance of shares, that a shareholder shall
 not, in respect of the relevant shares and in the absence of a contractual arrangement, or an obligation pursuant to the memorandum
 and articles of association, to the contrary, have any obligation to make further contributions to the Company's assets (except
 in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose
 or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

4.6 The
 search of records of proceedings available at the High Court Registry would not reveal any proceeding which has been placed under
 seal or anonymised (whether by order of the Court or pursuant to the practice of the High Court Registry).

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to our firm under the heading "Legal Matters" in the Registration Statement. In providing our consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the SEC Act or the rules and regulations of the Commission thereunder.

This opinion is addressed to you and may be relied upon by you, your counsel and purchasers of Shares pursuant to the Registration Statement. This opinion is limited to the matters detailed herein and is not to be read as an opinion with respect to any other matter.

Yours faithfully

Maples and Calder

**Appendix**

**Director's Certificate**

---

| | |
|:---|:---|
| To: | Maples and Calder |
|  | 5<sup>th</sup> Floor, Ritter House |
|  | PO Box 173 |
|  | Road Town |
|  | Tortola |
|  | British Virgin Islands |

---

Date: 28 November 2025

Dear Sirs

**Roadzen,Inc. (the "Company")**

I, the undersigned, being a director of the Company, am aware that you are being asked to provide a legal opinion in relation to certain aspects of British Virgin Islands law (the "**Opinion**"). Unless otherwise defined herein, capitalised terms used in this certificate have the meaning given to them in the Opinion. I hereby certify that:

1 The Memorandum and Articles of Association of the Company registered on 20 September 2023 remain in full force and effect and are unamended.

---

| | |
|:---|:---|
| 2 | The director resolutions dated 6 May 2021, 28 October 2021, 22 November 2021, 27 May 2025, 15 October 2025 and 22 November 2025 and the written resolutions of the committee of the board of directors dated 24 July 2025 (together with the Minutes, the "**Resolutions**") were duly passed in the manner prescribed in the Memorandum and Articles (including, without limitation, with respect to the disclosure of interests (if any) by directors of the Company). The Resolutions have not been amended, varied or revoked in any respect and the directors of the Company have not restricted or limited the powers of any future directors of the Company in any way. |

---

3 Immediately prior to the issue of the Ordinary Shares, the Company had sufficient authorised but unissued shares in order for the Ordinary Shares to be issued as contemplated by the Documents.

---

| | |
|:---|:---|
| 4 | The issue of the Ordinary Shares to the Selling Securityholders by the Company as contemplated by the Documents was authorised and such Ordinary Shares were legally issued, fully paid and non-assessable and that the consideration in respect of the Ordinary Shares was received by the Company and none of the Ordinary Shares were issued for less than par value. |

---

---

| | |
|:---|:---|
| 5 | That, in respect of any Ordinary Shares issued to the Selling Securityholders for non-cash consideration, at the time of the issuance of such Ordinary Shares, the cash value of any non-cash consideration was not less than the amount to be credited for the issuance of such Ordinary Shares. |

---

---

| | |
|:---|:---|
| 6 | The members of the Company (the "**Members**") have not restricted or limited the powers of the directors of the Company in any way. |

---

7 The directors of the Company at the date of the Resolutions and at the date of this certificate were and are: Steven Jack Carlson, Saurav Adhikari, Diane B. Glossman, Ajay Bhupendra Shah, Zoe Jane Ashcroft, Rohan Malhotra and Supurna VedBrat.

8 The members of the committee of the board of directors of the Company at the date of the Resolutions were: Steven Jack Carlson and Zoe Jane Ashcroft.

---

| | |
|:---|:---|
| 9 | The minute book and corporate records of the Company as maintained at its registered office in the British Virgin Islands and on which the Registered Agent's Certificate were prepared are complete and accurate in all material respects, and all minutes and resolutions filed therein represent a complete and accurate record of all meetings of the Members and directors (or any committee thereof) (duly convened in accordance with the Memorandum and Articles) and all resolutions passed at the meetings, or passed by written resolution or consent, as the case may be. |

---

---

| | |
|:---|:---|
| 10 | Prior to, at the time of, and immediately following execution of the Documents and effectiveness of the Registration Statement the Company was, or will be, able to pay its debts as they fell, or fall, due, and the transactions to which the Registration Statement relate will not cause the Company to become unable to pay its debts as they fall due. The Company has entered, or will enter, into the Documents for proper value, not with an intention to defraud or wilfully defeat an obligation owed to any creditor and the transactions contemplated thereby do not and will not give any creditor an unfair preference. |

---

11 Neither the Company nor any of its subsidiaries (if any) has an interest in any land in the British Virgin Islands.

---

| | |
|:---|:---|
| 12 | Each director of the Company considers the transactions contemplated by the Registration Statement to be of commercial benefit to the Company and has acted in good faith in the best interests of the Company, and for a proper purpose of the Company, in relation to the transactions which are the subject of the Opinion. |

---

---

| | |
|:---|:---|
| 13 | To the best of my knowledge and belief, having made due inquiry, the Company is not the subject of legal, arbitral, administrative or other proceedings in any jurisdiction. Nor have the directors and/or Members taken any steps to have the Company struck off or placed in liquidation, nor have any steps been taken to wind up the Company. Nor has any receiver been appointed over any of the Company's property or assets. |

---

14 The Company has at no time had employees operating within the British Virgin Islands.

15 To the best of my knowledge and belief, having made due inquiry, there are no circumstances or matters of fact existing which may properly form the basis for an application for an order for rectification of the register of members of the Company.

16 The Ordinary Shares issued, or to be issued, pursuant to Documents and re-sold by the Selling Securityholders pursuant to the Registration Statement have been, or will be, duly registered, and will continue to be registered, in the Company's register of members.

---

| | |
|:---|:---|
| 17 | The 133,464 Ordinary Shares referred to in the Registration Statement as being sold by Saurav Adhikari were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Saurav Adhikari in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 18 | The 84,551 Ordinary Shares referred to in the Registration Statement as being sold by Arete Growth Partners, LLC were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Arete Growth Partners, LLC in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 19 | The 33,820 Ordinary Shares referred to in the Registration Statement as being sold by Paul Henry Carlson were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Paul Henry Carlson in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 20 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Vishal Chhibbar were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Vishal Chhibbar in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 21 | The 926,171 Ordinary Shares referred to in the Registration Statement as being sold by El Cano MSF GP, LLC were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to El Cano MSF GP, LLC in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 22 | The 202,923 Ordinary Shares referred to in the Registration Statement as being sold by Eugon Investments Ltd. were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Eugon Investments Ltd. in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 23 | The 33,820 Ordinary Shares referred to in the Registration Statement as being sold by Benjamin Forman were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Benjamin Forman in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 24 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Paul S. Galant were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Paul S. Galant in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 25 | The 284,351 Ordinary Shares referred to in the Registration Statement as being sold by HVIP Interests LP were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to HVIP Interests LP in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 26 | The 169,102 Ordinary Shares referred to in the Registration Statement as being sold by Itabira Capital Ltd were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Itabira Capital Ltd in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 27 | The 169,102 Ordinary Shares referred to in the Registration Statement as being sold by Richard J. Waters Jr were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Richard J. Waters Jr in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 28 | The 81,243 Ordinary Shares referred to in the Registration Statement as being sold by Vatche Keverian were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Vatche Keverian in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 29 | The 14,411 Ordinary Shares referred to in the Registration Statement as being sold by Kapil Khetan were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Kapil Khetan in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 30 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Mikito Kiname were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Mikito Kiname in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 31 | The 487,459 Ordinary Shares referred to in the Registration Statement as being sold by Krishnan-Shah Family Partners, LP were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Krishnan-Shah Family Partners, LP in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 32 | The 4,387 Ordinary Shares referred to in the Registration Statement as being sold by Balasubramanian Kalyan Kumar were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Balasubramanian Kalyan Kumar in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 33 | The 67,641 Ordinary Shares referred to in the Registration Statement as being sold by Andrew Douglas Newman were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Andrew Douglas Newman in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 34 | The 101,461 Ordinary Shares referred to in the Registration Statement as being sold by OST LLC were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to OST LLC in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 35 | The 81,243 Ordinary Shares referred to in the Registration Statement as being sold by Muktesh Pant were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Muktesh Pant in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 36 | The 97,492 Ordinary Shares referred to in the Registration Statement as being sold by Rahul Puri were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Rahul Puri in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 37 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Rishi Chandna 2014 Separate Property Trust were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Rishi Chandna 2014 Separate Property Trust in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 38 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Nerur Shivkumar were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Nerur Shivkumar in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 39 | The 81,243 Ordinary Shares referred to in the Registration Statement as being sold by Bhanu Pratap Singh were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Bhanu Pratap Singh in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 40 | The 16,249 Ordinary Shares referred to in the Registration Statement as being sold by Aman Sridhar were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Aman Sridhar in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 41 | The 32,497 Ordinary Shares referred to in the Registration Statement as being sold by Arun Sinha Revocable Trust were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Arun Sinha Revocable Trust in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 42 | The 40,622 Ordinary Shares referred to in the Registration Statement as being sold by Ashok Vasudevan were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Ashok Vasudevan in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 43 | The 40,622 Ordinary Shares referred to in the Registration Statement as being sold by Meera Vasudevan were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Meera Vasudevan in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

---

| | |
|:---|:---|
| 44 | The 113,740 Ordinary Shares referred to in the Registration Statement as being sold by Sridhar Venkiteswaran were originally issued to Vahanna under the Sponsor Subscription Agreement and subsequently transferred from Vahanna to Sridhar Venkiteswaran in accordance with the laws, rules, procedures and other requirements applicable to shares registered on the NASDAQ Capital Market and recorded on the Company's Register of Members. |

---

I confirm that you may continue to rely on this certificate as being true and correct on the day that you issue the Opinion, unless I shall have previously notified you in writing personally to the contrary.

[*Signature page follows*]

---

| | |
|:---|:---|
| Signature: | */s/ Rohan Malhotra* |
| Name: | Rohan Malhotra |
| Title: | Director |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We hereby consent to the use in this Registration Statement on Form S-3 of Roadzen Inc. of our audit report dated June 26, 2025 of our audit on the consolidated financial statements of Roadzen Inc. as of March 31, 2025 and March 31, 2024 and for each of the two years ended March 31, 2025 and March 31, 2024.

We also consent to the reference of our firm under the heading "Experts" in such Registration Statement.

ASA & Associates LLP

Gurugram, India

November 28, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-3**

(Form Type)

**Roadzen Inc.**

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **Security<br> Type** | **Security<br> Class<br> Title** | **Fee<br> Calculation<br> or Carry<br> Forward<br> Rule** | **Amount<br> Registered** |  | **Proposed<br> Maximum<br> Offering<br> Price Per<br> Unit** |  | **Maximum<br> Aggregate<br> Offering<br> Price<sup>(1)(2)</sup>** | **Fee<br> Rate** | **Amount of<br> Registration<br> Fee** |
| **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** | **Newly Registered Securities** |
| Fees to Be Paid | Equity | Ordinary Shares, par value $0.0001 per share | 457(c) | 7946634 | (1) | $1.50 | (2) | $11919951.00 | $0.00013810 | $1646.15 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $11919951.00 |  | $1646.15 |
| **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** | **Total Fees Previously Paid** |  |  |  | $– |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  | $– |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $1646.15 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Ordinary shares will be
 offered for resale by the selling securityholders pursuant to the prospectus contained in the registration statement to which this
 exhibit is attached. The registration statement registers the resale of an aggregate of 7,946,634 ordinary shares of the registrant.
 Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the ordinary shares being registered hereunder
 include an indeterminable number of additional shares that may be issuable as a result of stock splits, stock dividends or similar
 transactions.

(2) Determined pursuant to
 Rule 457(c) under the Securities Act, solely for the purpose of calculating the registration fee, based on the average of the high
 and low prices of the Company's ordinary shares on The Nasdaq Global Market on November 25, 2025, which date is a date within
 five business days prior to the filing of this registration statement.

N/A